About this trial
Colonoscopy is a necessary item of physical examination for colorectal cancer. For high-risk groups, annual physical examination is the most effective way of early prevention; At present, a large amount of polyethylene glycol (PEG2000 - 4000) is often used as laxative and lubricant in colonoscopy. However, the widespread use of PEG may cause long-term and irreversible damage to intestinal microorganisms and bring great hidden dangers to health. The appendix has long been regarded as a redundant organ in evolution. The incidence of appendicitis ranks first in surgical acute abdomen. Traditionally, once acute appendicitis is diagnosed, it is usually treated with appendectomy. However, recent studies have revealed that appendectomy may be associated with psychiatric diseases, colorectal cancer, cardiovascular diseases and other diseases. The appendix is not only an important organ of the immune system, but also undertakes the function of storing and protecting intestinal microbes.. . This change may affect the function of the central nervous system through the microbe gut brain axis, and then pose a potential threat to the health and behavior of the host, such as increasing the risk of diseases such as Parkinson's disease. Based on this, this clinical trial aims to investigate (1) the changes of intestinal flora in the appendectomy population before and after colonoscopy in the process of polyethylene glycol intestinal preparation; (2) the differences between the changes of intestinal flora before and after colonoscopy in the appendicectomy population and the normal population in the process of flora recovery.
Eligibility criteria
Qualifiers
Aged 18-75 years.
Scheduled to undergo colonoscopy.
Generally healthy without major organ diseases.
For appendectomy group: history of appendectomy or right hemicolectomy (including appendectomy).
Disqualifiers
Allergy or intolerance to PEG laxatives.
Pregnant or lactating women.
Mental disorders.
Use of antibiotics within 6 months prior to study enrollment.
Trial design
Treatments tested in this trial
- Bowel Preparation with Polyethylene Glycol (PEG) Laxatives
Treatment groups
Sponsors and collaborators
Huaping Xie
Lead sponsor
Tongji Hospital
Sponsor institution